Thyrocare Technologies Limited (NSE: THYROCARE, BSE: 539871), a leading diagnostic service provider, has introduced the GLP-1 Health Check—comprehensive testing packages with up to 81 parameters. Priced from ₹2,799 and available pan-India, these packages aim to equip individuals and clinicians with precise diagnostic insights before, during, and after GLP-1 therapy.
Understanding GLP-1 and Its Growing Use
Glucagon-Like Peptide-1 (GLP-1) is a natural hormone that regulates blood sugar, modulates appetite, and slows gastric emptying. Medications known as GLP-1 agonists mimic this hormone and are increasingly used to manage type 2 diabetes and obesity. Their rising popularity for weight loss has generated widespread interest, prompting doctors to stress the need for regular monitoring to ensure safety and maximise treatment outcomes.
Purpose of the GLP-1 Health Check Packages
As per the press release, Thyrocare designed the GLP-1 packages to help individuals establish baseline health metrics before therapy begins and to track changes throughout treatment. Regular assessments enable early detection of side effects, nutritional gaps, and metabolic shifts, thereby supporting safe and effective use of GLP-1 medicines under medical supervision.
Addressing Key Health Risks in Diabetes and Obesity
Since people with obesity and type 2 diabetes often face insulin resistance, elevated blood sugar, abnormal cholesterol levels, fatty liver, and increased cardiovascular risk, Thyrocare developed these packages in collaboration with leading medical specialists. The curated tests monitor lipid profile, fasting glucose, fasting insulin, HOMA-IR, liver function, and cardiac risk markers to evaluate treatment response.
Monitoring Organ Health and Nutritional Status
Clinicians recommend evaluating kidney function before initiating GLP-1 therapy and periodically thereafter to detect dehydration or electrolyte imbalances. Moreover, because GLP-1 medicines significantly reduce appetite, they may lead to nutritional deficiencies or anemia. Therefore, the packages include tests for vitamin D, vitamin B12, and hemoglobin. To ensure complete safety, they also assess pancreatic enzymes (amylase, lipase) and thyroid function (T3, T4, TSH), as some patients may experience pancreatitis or thyroid-related complications.
Comprehensive Testing Under One Package
By integrating all essential tests into a single offering, Thyrocare simplifies comprehensive monitoring for individuals undergoing GLP-1 therapy, ensuring easier access to all relevant diagnostics.
Expert Perspectives on the Importance of Monitoring
Rahul Guha, MD & CEO of Thyrocare Technologies Ltd., stated, “As GLP-1-based medicines gain traction in India for weight management and diabetes, reliable diagnostic support becomes crucial. These therapies deliver strong results when used responsibly, and consistent monitoring enhances their effectiveness. Our goal is to make this monitoring process accessible to everyone.”
Highlighting the clinical importance, Dr. Shehla Shaikh, MD (General Medicine), DM (Endocrinology), noted, “As obesity grows into a global health concern, pairing GLP-1 therapy with structured, ongoing monitoring is essential. Baseline and periodic testing ensure nutritional balance, organ well-being, and long-term safety.”
Easy Access Through Multiple Platforms
Individuals can book these packages through Thyrocare, PharmEasy, and partner networks. By offering extensive metabolic testing at an affordable cost, Thyrocare continues to advance preventive and precision healthcare for people managing diabetes, obesity, or overall metabolic wellness.